Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Kilitch Drugs (India), Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Kilitch Drugs (India)

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price101.2
Previous Share Price108.3
Price Change -7.10
Change % -6.56%
Volume18.08 K
Five Day Avg Vol15.19 K
Last Business Date28-Feb-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -9.55 -8.62
Two Weeks -18.60 -15.53
One Month -23.65 -18.94
Three Months -14.95 -12.87
Six Months -8.90 -8.08
One Year -83.60 -45.24

Highs / Lows

One Week117.496.8
Two Weeks122.096.8
One Month136.4596.8
Three Months141.896.8
Six Months142.596.8
One Year219.092.95

Key Moving Average

5 Days 108.6107.501
15 Days 115.2113.4
20 Days 116.783115.068
50 Days 121.891119.238
100 Days 121.211122.301
200 Days 128.785129.577
Detailed MA Analysis of KILITCH ...

Key Technical Indicators

MACD -4.40
RSI 18.24
RSI (Smooth) 26.48
ADX 29.47
Chaikin Money Flow -0.218
Williams %R -84.93
PSAR 123.90
Detailed Tech Analysis KILITCH ...

Financial Data Highlights

Market Cap155.63
Book Value/ Share78.55
Enterprise Value15.79
Revenue TTM60.86
Gross Profit TTM33.47
Revenue /Share TTM39.59
Consensus Target47.00
Key Financial Highlights KILITCH ...

Financial Ratios of KILITCH

Div Yield0.450
Trailing PE60.23
Forward PE0
Key Financial Ratios of KILITCH ...

Key Profit & Loss Data

Net Inc 3.83 25.63 %
Ops Income6.87 51.99 %
Revenue82.49 61.71 %
Ops Expense75.62 62.62 %
PBT8.59 40.59 %
Gross Profit33.47 37.96 %
Div Paid-0.950 2228.43 %

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR10.1510.03
Week PR20.6020.36
Month PR39.6539.18
5 Day Period5.325.20
10 Day Period6.886.43
5 Week Period14.6913.20
3 Months Period23.3221.29
Price Range /Volatility KILITCH ...

Highlights & Chart Patterns of Kilitch Drugs (India)

Share has hit Six Months high on 28-Feb-20.
Stock has fallen by more than 10% in last two weeks from its highest level of 122.0 dt 17-Feb-20.
Stock has fallen by more than 15% in last One Month from its highest level of 136.45 dt 06-Feb-20.
Stock has fallen by more than 25% in last three Month from its highest level of 141.8 dt 17-Dec-19.
Stock has fallen to less than half in last One Year from its Highest level of 219.0 dt 18-Apr-19.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Spinning top Candlestick pattern was formed by Kilitch Drugs (India) on 27/02/2020 Prior to pattern formation this share was in downtrend.
More Chart Patterns Kilitch Drugs (India) ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Kilitch Drugs (India)

Date Open High Low Close Volume
28-Feb-20 105.00 106.95 96.80 101.20 18085
27-Feb-20 108.65 109.95 106.10 108.30 5552
26-Feb-20 110.00 110.70 107.70 109.20 10778
25-Feb-20 112.50 114.30 110.00 110.95 5259
24-Feb-20 108.00 117.40 107.00 113.35 36256
20-Feb-20 116.75 116.75 108.00 110.75 19874
19-Feb-20 117.00 117.95 112.00 113.40 17374
18-Feb-20 117.00 117.00 112.45 115.35 13530
17-Feb-20 118.80 122.00 111.00 117.45 15089
14-Feb-20 118.00 122.25 117.75 119.80 14891
About Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrups, and oral powders in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and a range of nutritional products comprising CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems, and used as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.